NAD(P)H:quinone oxidoreductase 1 (NQO1) is a cytosolic enzyme that protects cells against chemical and radiation-induced oxidative stress and skin cancer. Disruption of NQO1 gene in mice showed thinning of skin epithelium and loss of cytokeratin 14, an early marker of skin differentiation. Immunohistochemistry and western analysis demonstrated downregulation of p63 in NQO1À/À mouse skin, as compared with wild-type (WT) mouse. Further analysis including modulation of NQO1 expression revealed a direct correlation between the levels of NQO1 and p63 in skin-derived keratinocytes and dermal fibroblasts. Modulation of proteasomal activity revealed that p63 is degraded by 20S proteasome and that this degradation is significantly rescued by NQO1. Coimmunoprecipitation studies showed that NQO1 interacts directly with p63 but not 20S to protect against this degradation. In addition, benzo[a]pyrene treatment led to induction of NQO1 and stabilization of p63 in WT but not in NQO1À/À mouse skin and keratinocytes. These data suggest that NQO1 controls stabilization of p63 and progression towards keratinocyte differentiation leading to normal skin development and presumably skin carcinogenesis.
Introduction
NAD(P)H:quinone oxidoreductase 1 (NQO1) is a cytosolic phase II biotransformation enzyme, which catalyzes two-electron reduction and detoxification of quinones (Ross et al., 2000) . Two-electron reduction of quinones catalyzed by NQO1 competes with oneelectron reduction of quinones catalyzed by cytochromes P450, and leads to the formation of hydroquinone, a species that is quickly metabolized by other phase II biotransformation enzymes and removed from the cells. Unlike NQO1, one-electron reduction of quinones carried out by cytochrome P450 complexes leads to the formation of semiquinones and other reactive oxygen species. Therefore, NQO1 is considered a protective enzyme. NQO1 is ubiquitously expressed in all tissues (Talalay et al., 1995; Ross et al., 2000) and its expression is increased in response to chemical and radiation exposure (Jaiswal, 2004) . NQO1 detoxifies benzo [a] pyrene (BP) quinones thus reducing the BPinduced mutagenicity and carcinogenicity Jaiswal, 1994, 1998; .
The p53 family of transcription factors consists of p53, p63 and p73, each have multiple isoforms, eliciting various effects on downstream regulators of cell cycle progression and apoptosis (Moll and Slade, 2004; Pietsch et al., 2008) . Though p63 is present in all tissues, the role of p63 is most relevant to epithelial tissues such as skin (King and Weinberg, 2007; Koster et al., 2007a, b; Candi et al., 2008) . Such roles in dermal development are still being elucidated, although knockout mouse studies have confirmed that the loss of p63 is sufficient to prevent normal epithelial development (Yang et al., 1999) . The p63À/À mice die at or before birth, lacking skin and with profound limb underdevelopment, which can be partially rescued by returning p63 expression to the mice, suggesting the vital role(s) played by p63 in skin differentiation (Mills et al., 1999) .
BP is a potent environmental carcinogen, which is capable of inducing considerable DNA damage and cell toxicity (Gelboin, 1980) . Conversion of BP into metabolites is required for toxicity, and is mediated mainly by CYP450, a process that leads to production of quinones and reactive oxygen species (Guengerich, 1988) . NQO1, expression of which and activity are induced following exposure to xenobiotics and other sources of oxidative stress (Talalay et al., 1995; Radjendirane et al., 1997) , exhibits activity against these quinone metabolites, and this quinone detoxifying activity has been well-characterized as one mechanism for NQO1 protection against BP-induced mutagenicity and carcinogenesis Jaiswal, 1994, 1998; .
In this report, we demonstrate that inactivation of NQO1 gene in mice led to the loss of cytokeratin 14 (K14), an early marker of skin differentiation and thinning of skin epithelium. Previous studies from our laboratory have shown increased sensitivity of NQO1À/À mice to BP-induced skin cancer (Long et al., 2000) . NQO1À/À mouse skin, as compared with wild-type (WT) mouse demonstrated downregulation of p63. Further analysis including modulation of NQO1 expression revealed a direct correlation between the levels of NQO1 and p63 in skin-derived keratinocytes and dermal fibroblasts. We also demonstrate that p63 is degraded by 20S proteasomes. NQO1 physically interacts with p63 and protects against 20S proteasomal degradation of p63. This leads to the stabilization of p63, increased expression of keratinocyte differentiation markers, which may provide the mechanism leading to normal skin epithelium development and protection against BP-induced skin carcinogenesis.
Results
Studies using NQO1À/À mice show that in skin, as in all tissues, NQO1 expression and activity is essentially lost and cannot be detected (Long II et al., 2000) . H&E stained skin sections from WT, NQO1À/À and NQO2À/À were compared and analyzed for lesions ( Figure 1a) . Intriguingly, NQO1À/À skin sections showed thinning of epithelium, as compared with WT mice skin. NQO2À/À skin sections did not demonstrate thinning of epithelium as observed in NQO1À/À mice. Immunohistochemistry of skin sections from WT, NQO1À/À and NQO2À/À mice revealed significantly decreased p63 and downstream gene keratin 14 in the NQO1-null but not NQO2-null mice (Figures 1b and c) . Western analysis of these mice skin supported the immunohistochemistry results showing a decrease in keratin 14 in NQO1À/À but not NQO2À/À skin ( Figure 1c) . Interestingly, NQO1À/À mice have demonstrated significantly increased sensitivity to development of BP and 7,12-dimethylbenzanthracene-induced skin tumors, as compared with WT mice (Long et al., 2000 (Long et al., , 2001 . Most of the tumors were squamous cell papilloma and some were carcinomas.
Western analysis of skin tissue demonstrated that the expression of p63 was strongly downregulated in NQO1À/À skin, as well as in skin from NQO1/NQO2 double-knockout mice, whereas mice lacking only NQO2 did not lack p63 (Figure 2a ). Epidermal keratinocyte cell lines derived from BP-induced skin tumors in these mice also showed similar downregulation of p63 in cells lacking NQO1 expression, whereas no similar effect on p63 was observed in mice and cell lines lacking NQO2, with the DNp63a isoform existing as the dominant isoform (Figure 2b ). These results together with immunohistochemistry observations (Figure 1b) suggested that NQO1 and not NQO2 regulated p63 in mouse skin. The relationship between NQO1 and p63 expression was further explored as p63 is known to have a significant role in the development of skin epithelium (Yang et al., 1999) . We included primary dermal fibroblasts because of problems inherent in keratinocyte transfection efficiency. Overexpression of NQO1 in dermal fibroblasts led to the significant increase in p63 expression (Figure 2c ), whereas knockdown of endogenous NQO1 expression with small interfering RNA led to the profound loss of p63 expression, which while variable in extent was consistently significant across experiments (Figure 2d ). This loss of endogenous p63 expression was blocked and in fact p63 levels were stabilized to levels above physiological levels due to inhibition of steady-state proteasomal degradation, however, by pretreatment with the wellcharacterized proteasome inhibitor MG-132, suggesting that NQO1 controls the stability of p63 and such stability is mediated through proteasomal degradation. In the same experiment, positive control p53 followed same pattern as p63 and reported earlier (Gong et al., 2007) .
Quantitative PCR experiments revealed that there was a decrease in p63 RNA transcripts in NQO1-null keratinocytes and tissues relative to WT controls. However, the percentage decrease of RNA in these cells and tissues was much smaller than the percentage decrease of protein levels observed in NQO1-null samples (Figures 2a and b) . These findings suggest that although NQO1 may exert some transcriptional control over p63, the more significant mechanism by which NQO1 can control p63 expression is likely to be at the level of protein stability.
The E3 ubiquitin ligase Itch has been previously investigated as a negative regulator of p63 expression in some systems , and so was an initial target of our studies on NQO1 control of Itch as means to control p63. Western blot studies revealed, however, that there was no significant increase in Itch expression in NQO1-null keratinocytes (Figure 3a) , suggesting that this system is not primarily responsible for decreased p63 in these cells. NQO1 is known to protect p53 family members p53 and p73 against 20S proteasomal degradation (Asher et al., 2005; Gong et al., 2007) . 20S proteasomes degrade unubiquitinated p53. In response to stress, NQO1 is induced to interfere with 20S degradation of p53 (Gong et al., 2007) . This leads to the stabilization of p53 and cellular protection. Therefore, the role of NQO1 in protection against ubiquitinindependent 20S proteasomal degradation was investigated. In vitro translated DNp63a and p53 when incubated with purified 20S proteasomes led to the degradation of both proteins within 2 h (Figures 3b-d) .
We then investigated what effect NQO1 may have on this proteasomal degradation using in vitro degradation assays, and discovered that indeed, NQO1 along with cofactor NADH is sufficient to protect DNp63a isoform from 20S-mediated destruction (Figure 3b , upper panels). This result was similar as observed with NQO1/NADH protection of p53 against 20S proteasomal degradation ( Figure 3b , Lower Panels; Gong et al., 2007) . Inclusion of dicoumarol, a competitive inhibitor of NADH binding to NQO1, inhibited NQO1/NADH protection of DNp63a against 20S proteasomal degradation ( Figure 3c ). We then examined the role of known mutations in NQO1, such as the tyrosine 126-128 area of the L5 loop, which has been identified as relevant to NAD(P)H binding and in p53 interaction (Asher et al., 2006) , as well as the clinically-relevant proline-serine 187 mutation, which interferes with NQO1 protein stability and therefore possible ability to regulate stability of other factors (Chen et al., 2000) . In in vitro degradation assays we compared DNp63a degradation by purified 20S proteasome without NQO1 (No NQO1), with WT NQO1, and mutants (Y126/128A, P187S), which were constructed and verified in our laboratory. We observed that while WT NQO1 and the P1287S mutated form both protected DNp63a against 20S-mediated degradation over 4 h, the Y126/129A mutated form of NQO1 did not have the same protective effect (Figure 3d ). This suggests that one or both tyrosines at 126/128 in the L5 loop of NAD(P)H and quinone binding pocket has a key role in NQO1-DNp63a interactions, which stabilize DNp63a. The proline at 187, although clinically relevant (Chen et al., 2000) , does not appear to directly regulate protection of DNp63a against 20S proteasomal degradation. The role of ubiquitin-independent proteasomal degradation of DNp63a was further explored using A31N-ts20 mouse fibroblasts. These cells express a thermosensitive E1 ubiquitin ligase, which is active at 35 but inactive at 39 1C (Salvat et al., 2000) . Results indicate that DNp63a stability is dependent on NQO1 expression, as is evident by decrease of DNp63a expression following NQO1 knockdown. The extent of DNp63a degradation subsequent to the loss of NQO1 at ubiquitin-permissive 35 1C is similar to the extent observed at ubiquitininactive 39 1C (Figure 3e ), which suggests that the role of ubiquitin-dependent 26S proteasomal degradation of DNp63a is relatively minor in comparison with ubiquitin-independent 20S-mediated degradation. These results were similar as observed with p53 ( Figure 3e ) and published earlier (Gong et al., 2007) . It is noteworthy that changing of culture temperature from 35 to 39 1C led to an increase in p53 but not in p63 (Figure 3e . This suggested that p53 and not p63 is also degraded through ubiquitination/26S proteasomes. Subsequently, we investigated whether, similar to what we have previously reported with p53 (Gong et al., 2007) , NQO1 is directly interacting with DNp63a alone to inhibit proteasome-mediated degradation of DNp63a. Immunoprecipitation studies showed that DNp63a is capable of interaction with 20S proteasome (Figure 4a ), and similarly we determined that DNp63a is directly interacting with NQO1. We then investigated whether, similar to what has been reported to occur with p73 (Asher et al., 2005) as opposed to what has been reported by us to occur with p53, NQO1 is directly interacting with the 20S proteasome to prevent degradation of DNp63a. Immunoprecipitation studies found no interaction between NQO1 and 20S proteasome (Figure 4a ). These results indicate that while DNp63a interacts directly with and is degraded significantly by the 20S proteasomal complex, NQO1 is capable of interacting with and protecting DNp63a against 20S-mediated degradation and this effect appears to occur without direct interaction with the 20S complex itself. This further suggested that the pool of DNp63a protein, which interacts with NQO1 is separate from the pool which interacts with the 20S proteasome, and that direct interaction between NQO1 and DNp63a prevents interaction and eventual degradation by 20S proteasome. We next looked to determine if the sterile alpha motif (Arrowsmith, 1999) domain of DNp63a has a role in NQO1-DNp63a interactions. In this regard we performed coimmunoprecipitation experiments with cells cotransfected with WT NQO1-V5 and either Flag-tagged DNp63a or DNp63g. We found that there was no decrease in NQO1-p63 interaction with the SAM-lacking DNp63g isoform, compared with NQO1-DNp63a interaction (Figure 4b ). This suggests that the SAM may not be an important domain of p63 (a) Expression of DNp63a is dependent on the presence of NQO1 in vivo. Mice aged 7-10 weeks were euthanized and shaved, and skin was collected and frozen, and homogenized in RIPA. Aliquots were run on 10% gel and probed against GAPDH, NQO1, NQO2, p53 and DNp63a. A bar graph shows the percentage decrease of protein levels (measured by densitometry and normalized to wild type (WT) mice) compared with WT mice relative to the percentage decrease in RNA (measured by qPCR and normalized to WT mice). A number 41.0 indicates that the decrease in protein levels exceeds the decrease in RNA levels. (b) Expression of DNp63a is dependent on the presence of NQO1 in vitro. Mouse-derived keratinocytes were plated in 10 cm dishes and harvested in RIPA, run on 10% gel, and probed against GAPDH, NQO1, NQO2, p53 and p63-HRP. A bar graph shows the percentage decrease of protein levels (measured by densitometry and normalized to WT) compared with WT relative to the percentage decrease in RNA (measured by qPCR and normalized to WT mice). (c) NQO1 overexpression in primary dermal fibroblasts leads to the upregulation of DNp63a. Cells were plated into 10 cm dishes and transfected with either empty vector or pcDNA-NQO1-V5 for 48 h, harvested in RIPA, then run on 10% gel and probed against GAPDH, NQO1 and p63-HRP. The cells were also analyzed for p63 RNA by qPCR. The bar diagram on right shows NQO1 and p63 band intensities. Bar diagram on bottom shows DNp63a RNA levels relative to control. (d) Knockdown of NQO1 leads to loss of DNp63a and p53, which is protected by MG132-mediated proteasome inhibition. Fibroblasts were transfected with siNQO1 or control siRNA for 48 h and then exposed to either fresh media or proteasome inhibitor 5 mM MG-132 for 8 h. Western blot analyzed NQO1, DNp63a, p53 and GAPDH.
NQO1 control of p63 BA Patrick et al in its stability against 20S proteasomal degradation. We then investigated whether the NQO1 mutations investigated earlier, which affected 20S-mediated degradation of DNp63a would affect direct interaction. Coimmunoprecipitation studies in cells cotransfected with Flag-tagged DNp63a and either WT NQO1-V5, NQO1-Y127/129A-V5 or NQO1-P187S-V5 revealed that interaction between NQO1 and Flag-tagged DNp63a does indeed require the Y127/129 residues to be intact but not the P187 residue, as in only the Y127/129A mutant interaction was significantly decreased, not in the P187S mutant (Figure 4c) .
Subsequent studies were performed to determine the physiological relevance of NQO1-mediated protection of DNp63a in response to classical models of carcinogenesis and stress-response. These in vivo and in vitro studies involved the well-characterized environmental carcinogen BP and the antioxidant tert-butylhydroquinone, which induces upregulation of antioxidant response element-mediated enzymes such as NQO1. In both WT skin tissues and keratinocytes the induction of NQO1 by BP was followed by strong DNp63a upregulation, whereas induction was strongly muted in NQO1À/À tissues and keratinocytes (Figure 5a ). Similarly, tert-butylhydroquinone induction of NQO1 was followed by DNp63a upregulation in WT but not NQO1À/À keratinocytes (Figure 5b) . Follow-up studies in the same tumor-derived keratinocytes showed that induction of NQO1 through stress-response pathways, such as ultraviolet light and gamma ionizing irradiation, (b) NQO1/NADH protects against 20S degradation of DNp63a and p53. Product from 100 ng of in vitro-translated p53 and DNp63a isoforms were incubated with 2 mg 20S proteasome in degradation buffer at 37 1C for 2 h with or without recombinant NQO1 and NADH (1 mM). Reactions were quenched with sample buffer and analyzed by western blotting. (c) Dicoumarol inhibits NQO1/NADH protection against 20S degradation of DNp63a. In vitro-translated DNp63a was incubated with 20S and/or NQO1 and/or 1 mM NADH and/or 300mM dicoumarol to determine the effect of specific inhibition of NADH binding to NQO1 on DNp63a stability. Western blotting analyzed DNp63a NQO1 and 20S. (d) Mutations in NQO1 interfere with NADH-dependent protection against 20S degradation of DNp63a. Product from 1 mg of recombinant DNp63a was incubated at 37 1C for 0, 1, 2 and 4 h with 2 mg 20S proteasome in degradation buffer with either in vitro-translated WT NQO1 or NQO1-V5 mutated at either Y126/128A or P187S with 1 mM NADH to determine the effect of these mutations of NQO1 on DNp63a stability. Western blotting analyzed DNp63a NQO1-V5 and 20S. Bar graph below is densitometry: dark bars are values at 0 h and white bars are corresponding values at 4 h, each normalized to 0 h values. (e) NQO1 stabilizes against ubiquitin-independent degradation of DNp63a and p53. E1 ligasethermosensitive A31N ts20 fibroblasts were transefected in 6 cm dishes at 35 1C with siNQO1 or control siRNA for 48 h and one set transferred to ubiquin-inactive 39 1C for 24 h before lysis. Densitometry of bands are shown below western blots.
NQO1 control of p63
BA Patrick et al also led to significant increase in DNp63a expression as determined by densitometry (Figures 5c and d) . These data strongly suggest that NQO1 induction is crucial to the increase in expression of DNp63a following exposure to environmental stressors.
Discussion
It is an established fact that DNp63a significantly contributes to the development of normal skin epithelium (Mills et al., 1999; Yang et al., 1999) . Therefore, the observation of thinning of epithelium in NQO1À/À skin suggested a connection between NQO1 and DNp63a. Further studies indeed revealed that DNp63a was downregulated in skin from NQO1À/À mice. The NQO2À/À mice skin showed normal levels of DNp63a and absence of thinning of skin epithelium. These studies together revealed that NQO1 and not NQO2 regulated DNp63a and normal development and protection of skin epithelium. The downregulation of DNp63a in NQO1À/À mice also raised an interesting question. How does NQO1 regulate DNp63a? The experiments demonstrated that the modulation of NQO1 levels led to the parallel changes in DNp63a levels. In addition, NQO1 small interfering RNA-mediated loss of DNp63a was rescued by proteasome inhibition. These results suggested that NQO1 protected specifically against proteasomalmediated degradation of DNp63a. Further studies showed that NQO1 protected against 20S proteasomal degradation of DNp63a. This was confirmed by in vitro studies showing that purified 20S proteasome, lacking the 19S component of the larger 26S complex, is capable of degradation of DNp63a. These studies also show that the presence of NQO1 is sufficient to protect DNp63a protein levels, establishing that NQO1 is capable of interfering with 20S-mediated DNp63a degradation. The results also revealed that NQO1 protection against 20S proteasomal degradation of DNp63a requires NADH binding to NQO1. This was evident from the requirement of NADH for complete protection against 20S degradation of DNp63a and the dicoumarol inhibition of NQO1 protection against 20S degradation of DNp63a and the loss of protection in case of NADHbinding mutant NQO1Y127/129A. Dicoumarol is a competitive inhibitor of binding of NADH to NQO1. This also raises interesting questions regarding the role of NADH in NQO1 protection against 20S degradation of p63. As is revealed through IP studies, the NQO1 protection occurs by directly binding to DNp63a and not to 20S itself. The loss of this protection in NQO1À/À mice led to the downregulation of DNp63a and thinning of skin epithelium. The thinning of epithelium could have been due to decreased differentiation of epithelial cells and/or damage due to endogenous/environmental stress response(s).
It is noteworthy that NQO1 also contributes to the transcription of p63 as evident from significantly decreased NQO1 transcripts in skin tissues from NQO1À/À mice, as compared with WT mice. The NQO1 control of transcription of p63 is in addition to its role in stabilization of p63 protein. Therefore, both stabilization of protein and increase in transcription contribute to NQO1-mediated regulation of p63. The NQO1 control of p63 transcription has to be mediated through NQO1 regulation of factor(s) that regulate transcription of p63 and signaling pathway remains to be determined. NQO1 is a stress responsive gene (Jaiswal, 2004) . The expression of NQO1 is coordinately activated along with another 200 þ genes in response to chemical and radiation stress (Jaiswal, 2004) . This was also evident from increased expression of NQO1 in response to BP, antioxidant and ultraviolet light light (Present studies). This induction is critical in protection against damage to skin, against exposure to chemicals and radiation. NQO1-mediated protection of DNp63a allows accumulation of DNp63a in keratinocytes and subsequent accumulation of DNp63a-downstream keratinocyte differentiation genes such as K14 (Romano et al., 2009 ) and in addition, may constitute a mechanism for the well-established protection (Radjendirane et al., 1998) .
The role of DNp63a in chemical/radiation-induced skin cancer is expected but remains controversial (Moll and Slade, 2004) . Both NQO1À/À and NQO2À/À mice demonstrate significantly increased sensitivity to BP and dimethylbenzanthracece-induced skin carcinogenesis, as compared with WT mice (Long et al., 2000 (Long et al., , 2001 Iskander et al., 2004) . The studies have also suggested that lower induction of p53 and apoptosis in NQO1À/À and NQO2À/À mice led to skin carcinogenesis (Gong et al., 2007; Shen et al., 2010) . It is possible that lack of induction of DNp63a and proper differentiation of epithelial cells also contributed to skin carcinogenesis. This might also explain higher sensitivity of NQO1À/À to skin carcinogenesis than NQO2À/À mice (Long et al., 2000 (Long et al., , 2001 Iskander et al., 2004) .
A hypothetical model of NQO1-DNp63a interaction in epidermal tissues shows that in WT, NQO1-positive cells and skin tissues, DNp63a is protected against 20S-mediated proteasomal degradation because of sequestration by NQO1 in cytosol (Figure 6 ). It is WT and NQO1À/À mice were shaved and either 100 ml of acetone or 1200 nmol of benzo[a]pyrene in acetone was applied to skin. After 24 h, mice were euthanized and skin was collected and frozen, and samples were prepared in RIPA buffer and run on 10% gel, and probed against GAPDH, NQO1 and p63 HRP. In cells, WT and NQO1À/À keratinocytes were plated in 10 cm dishes and exposed to 1800 nmol benzo[a]pyrene in DMSO for 24 h, then harvested in RIPA buffer and run on 10% gel, and probed against GAPDH, NQO1 and p63 HRP. (b) Antioxidant response-mediated induction of NQO1 leads to DNp63a the upregulation in keratinocytes. WT and NQO1À/À keratinocytes were plated in 10 cm dishes and exposed to tert-butylhydroquinone (tBHQ) in DMSO for 24 h, then harvested in RIPA buffer and run on 10% gel, and probed against GAPDH, NQO1 and p63 HRP. (c) Stress-response induction of NQO1 in tumor-derived keratinocytes induces DNp63a. Cells were plated in 10 cm dishes and subjected to 0-30J/m2 UVB, followed by 4 h rest at 37 1C and probed against GAPDH, NQO1 and p63 HRP. (d) Induction of NQO1 in tumor-derived keratinocytes leads to the upregulation of DNp63a. Cells were plated in 10 cm dishes and subjected to 0-6 Gy of g-IR, followed by 4 h rest at 37 1C and probed against GAPDH, NQO1 and p63 HRP.
important to note that this hypothesis for protection of DNp63a by NQO1 does not require that NQO1 interact directly with the 20S proteasome but hypothesizes that NQO1 may interact with DNp63a at some region, which is different from the region with which DNp63a interacts with the 20S proteasome (to facilitate normal 20S-mediated DNp63a degradation). This lack of interaction between NQO1 and 20S proteasome has been observed before in our previous studies regarding NQO1 protection of p53 from 20S-mediated proteasomal degradation (Gong et al., 2007) . This protection allows buildup of DNp63a within the cell, which is then available for DNp63a-mediated downstream biological effects such as induction of markers of keratinocyte differentiation (for example, K14) (Fuchs, 1996) , and thereby allowing correct physiological differentiation of skin tissues. DNp63a is degraded and does not induce in NQO1À/À mice deficient in NQO1. This leads to loss of protection, thinning of epithelium and presumably skin cancer.
Materials and methods
Animals, cell culture, inhibitors, mutants and treatments C57BL/6 mice, which are NQO1-null, NQO2-null and NQO1/ NQO2 double-null were derived as was reported previously (Radjendirane et al., 1998; Long et al., 2002; Das et al., 2006) . Mouse keratinocytes were derived from dimethylbenzanthracece-induced skin tumors as was described previously (Ahn et al., 2006) and cultured in DMEM/10% fetal bovine serum/ 1% antibiotics and subcultured 2-3 Â per week. A31N-ts20 BALB/C mouse fibroblast line was grown in similar media to keratinocytes. Human primary fibroblasts were cultured in DMEM/10% fetal bovine serum/1% antibiotics and subcultured 3 Â per week. Mouse liver-cancer cell line Hepa-1 was cultured in DMEM/10% fetal bovine serum/1% antibiotics and subcultured 3 Â per week. 20S proteasome complex inhibitors MG132 was obtained from Sigma (St Louis, MO, USA) and diluted in DMSO. DNA transfections were performed using Effectene (Qiagen, Valencia, CA, USA) and small interfering RNA transfections were performed using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA). Cell lines not lab-derived were obtained from ATCC (Mannassas, VA, USA). Mutants of human NQO1 were produced using GeneTailor site-directed mutagenesis kit (Invitrogen) according to the manufacturer's suggestions, using sequence provided by Pubmed (NM_000903) to determine relevant residues from previously-cloned HuNQO1 vector, and all clones were subcloned into pCDNA 3.1 vector for use.
Histology
A 7-9 week-old male WT, NQO1À/À and NQO2À/À mice were euthanized by isofluorane according to IACUC-approved protocols, and dorsal skin areas were shaved with clippers and removed by surgery. The skin was immediately fixed in Figure 6 Hypothetical model of NQO1-mediated protection of DNp63a against 20S proteasomal degradation in cells. In WT (NQO1-positive) cells, NQO1 can directly interact with and prevent some DNp63a interaction with 20S proteasome, sparing DNp63a protein levels, thereby allowing p63-mediated processes such as keratinocyte differentiation. During stress, NQO1 induction allows increased DNp63a protection. In NQO1À/À cells, loss of NQO1 leaves DNp63a unprotected and therefore more likely to undergo 20S-mediated degradation, decreasing the intracellular DNp63a pool and thereby decreasing DNp63a-mediated processes. During stress, only limited DNp63a induction is possible due to lack of stabilizing activity from NQO1.
K14
NQO1 control of p63 BA Patrick et al formalin overnight at room temperature, and delivered to University of Maryland Dermatopathology laboratory for paraffin embedding and microtomy, as well as mounting to charged slides and H&E staining.
Western blot analysis
Cell lysates and tissue homogenates were homogenized/lysed in RIPA buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% Deoxycholate, 1% NP-40, 1% Triton X-100, 1 mM PMSF and protease inhibitor coctail (Roche, KonzernHauptsitz, Switzerland)) on ice and clarified by centrifugation at B10 000 g. Protein concentration was estimated by Bradford method with Bio-Rad reagent (Bio-Rad, Hercules, CA, USA). SDS-PAGE analysis was performed as previously described (Gong et al., 2007) . Antibodies against NQO1 was derived in-lab as described previously (Radjendirane et al., 1998) ; antibodies against DNp63a (4A4 with quantitation of the prominent band at 51-55 kDa), NQO2 (N15) and glyceraldehyde phosphate dehydrogenase, and protein A/G agarose were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). ECL reagent was purchased from GE Healthcare (Piscataway, NJ, USA) and Pierce Biotechnology (Thermo Fisher Scientific, Rockford, IL, USA).
Immunoprecipitation
Cells were plated into 150 mm cell culture dishes and grown until 75% confluence before transfection. At 48 h posttransfection dishes were washed in PBS and scraped in RIPA buffer with protease inhibitor cocktail and rotated at 4 1C for 20 min before centrifuging at 14 000 r.p.m. for 10 min to pellet debris. Supernatant was quantified and brought to 2 mg/ml in RIPA and precleared with washed protein A/G-agarose beads (Santa Cruz Biotechnology) for 1 h at 4 1C, followed by bead removal and immunoprecipitation overnight with 1:100 20S core subunit antibody (Calbiochem, San Diego, CA, USA), 1:1000 V5 antibody (Invitrogen), or 1:100 Flag antibodyconjugated agarose beads (Sigma). The next day fresh A/Gagarose beads were added for 2 h to bind antibodies and samples were washed twice in RIPA buffer before boiling 5 min in 2 Â SDS loading buffer.
Quantitative PCR Cells were cultured in 10 cm dishes and harvested using RNeasy (Qiagen) to purify total RNA, and DNA degraded using Turbo DNA-free (Ambion, Austin, TX, USA). After confirming quality through spectrophotometry and on agarose gel, RNA (25-100 ng) was used as a template for qPCR with appropriate TaqMan probes (Applied Biosystems, Foster City, CA, USA) according to manufacturer protocols, n ¼ 3 per group normalized against internal controls (Rox) and external controls (GusB for mouse keratinocytes, 18S rRNA for human fibroblasts) on ABI 7500 real-time-PCR system.
In vitro translation and 20S proteasomal degradation of translated protein Proteins were translated from lab-generated plasmids using TnT in-vitro translation kit (Promega, Madison, WI, USA) using cold methionine. Purified 20S proteasomal complex was purchased from Sigma and dissolved in DMSO. NQO1-V5 and pcDNA-DNp63a plasmid DNA were translated for 90 min at 30 1C, and 2 mg of this was incubated with 20S proteasome in Degradation Buffer (100 mmol/l Tris-Cl (pH 7.5), containing 150 mmol/l NaCl, 5 mmol/l MgCl 2 and 2 mmol/l DTT) as previously described (Gong et al., 2007) for various time points and quenched through freezing at À80 1C. Samples were separated on 12% SDS-PAGE and immunoblotted. Blots were probed with V5-HRP (to detect NQO1-V5), 20Sa5 and p63 (4A4-HRP) antibodies. In related experiments, in vitro translated NQO1 without or with NADH and dicoumarol were included and 20S degradation of p63 experiments repeated. Dicoumarol was dissolved in 3% NaOH in water for use, and NADH was dissolved in degradation buffer.
Immunohistochemistry Animals were euthanized with isofluorane according to IACUC-approved protocols and skin was removed using scissors. Shaved skin patches were fixed in formalin solution (Sigma) overnight and afterwards placed into cassettes and embedded in paraffin at University of Maryland Dermatopathology Laboratory. Paraffin blocks were sliced and sections were affixed to charged slides. Slides were hydrated in xylene, 100% EtOH, 95, 90, 70, 30%, followed by peroxidase blocking with 3% H 2 O 2 /MeOH, Retrievagen antigen retrieval (BD Pharmingen, Mississauga, ON, Canada) at B95 1C for 30 min, blocking 30 min in 5% goat serum/TBS-T, washing, and primary antibodies (1:1000 p63 4A4 or 1:50 K14) for 1 h, washing, followed by secondary antibody for 30 min, horse radish peroxidase developing for 10 min, DAB for 25 s, and hematoxylin counterstaining for 3 min, all according to manufacturers recommendations (Millipore, Billerica, MA, USA), followed by dehydration in EtOH and xylene, and sealing under coverslips with Permount (Fisher Scientific, Pittsburgh, PA, USA). Slides were photographed with Nikon Eclipse 80i upright microscope under Plan Apo Â 20/0.75 DIC N2 WD 1.0 and Plan Apo Â 40/0.95 DIC M/N2 WD 0.14 objectives, and fields were rotated as necessary to match. Nikon NIS-Elements BR 3.0 software was used with the microscope, along with DS-Fi1 bright-field camera. All photography was done at room temperature and files saved as jpeg format with each field subjected to 'auto-white balance' before capturing, with no other manipulation.
